HemaSphere
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherLIPPINCOTT WILLIAMS & WILKINS
- LanguageEnglish
- FrequencyMonthly
- Article Processing ChargesUSD 1200
- Publication Time7
- Editorial Review ProcessDouble anonymous peer review
- LanguageEnglish
- Society/Institute/SponsorEuropean Hematology Association
- FrequencyMonthly
- Publication Start Year2017
- Publisher URL
- Website URL
- Other charges
- Publication Time7
- Editorial Team
- Review ProcessDouble anonymous peer review
- Review Url
- Author instructions
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC, CC BY-SA, CC BY-NC-ND, CC BY-ND, CC BY-NC-SA
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 7% |
| 4-6 | 52% |
| 7-9 | 27% |
| >9 | 14% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has HemaSphere been publishing? 
The HemaSphere has been publishing since 2017 till date.
How frequently is the HemaSphere published?
HemaSphere is published Monthly.
Who is the publisher of HemaSphere?
The publisher of HemaSphere is LIPPINCOTT WILLIAMS & WILKINS.
How can I view the journal metrics of HemaSphere on editage?
For the HemaSphere metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of HemaSphere?
The eISSN number is 2572-9241 and pISSN number is 2572-9241 for HemaSphere.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Precision medicine, Bone marrow, Coagulopathy, Immune thrombocytopenia, Chimeric antigen receptor, Minimal residual disease, Dexamethasone, Cancer predisposition, Anemia, Von willebrand, Mantle cell lymphoma, Myelofibrosis, Fusion gene, Therapy-Related Acute Myeloid Leukemia, Ex vivo, Ibrutinib, Hematopoietic stem cell transplantation, Drug resistance, Overall survival, Essential thrombocythemia.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.